Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Invested Capital (2023 - 2025)

Arcutis Biotherapeutics has reported Return on Invested Capital over the past 3 years, most recently at 0.05% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.05% for Q4 2025, up 37.0% from a year ago — trailing twelve months through Dec 2025 was 0.05% (up 37.0% YoY), and the annual figure for FY2025 was 0.05%, up 42.0%.
  • Return on Invested Capital for Q4 2025 was 0.05% at Arcutis Biotherapeutics, up from 0.15% in the prior quarter.
  • Over the last five years, Return on Invested Capital for ARQT hit a ceiling of 0.05% in Q4 2025 and a floor of 0.95% in Q3 2023.
  • Median Return on Invested Capital over the past 3 years was 0.46% (2025), compared with a mean of 0.48%.
  • Biggest five-year swings in Return on Invested Capital: skyrocketed 49bps in 2024 and later grew 8bps in 2025.
  • Arcutis Biotherapeutics' Return on Invested Capital stood at 0.91% in 2023, then surged by 55bps to 0.41% in 2024, then soared by 89bps to 0.05% in 2025.
  • The last three reported values for Return on Invested Capital were 0.05% (Q4 2025), 0.15% (Q3 2025), and 0.35% (Q2 2025) per Business Quant data.